Trials / Completed
CompletedNCT05443763
Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program.
Detailed description
The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program. Research questions include: 1.) What are the effects of an intensive program on postural control and functional mobility for children with neurodevelopmental disorders? 2.) What are the effects of an intensive therapy program on dual tasking for children with neurodevelopmental disorders? 3.) What are the perceptions of caregivers of a multidisciplinary intensive therapy program for their children with neurodevelopmental disorders? Data will be gathered before and after the intensive program as part of usual care and ambulatory children will be further assessed in the motion analysis lab. Caregivers will complete a questionnaire about satisfaction with services and also a 4 question open-ended question survey about their experience with intensive therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | An interdisciplinary intensive therapy program | Children will receive physical, occupation, and/or speech therapy 1-3 hours/day each for 4-5 days/week x 4 weeks. |
Timeline
- Start date
- 2022-05-23
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2022-07-05
- Last updated
- 2023-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05443763. Inclusion in this directory is not an endorsement.